Robert Legaspi was 9 years old when he was first diagnosed with acute lymphoblastic leukemia. This year, at age 27, his leukemia returned for the fourth time. This time was different, though — on May 20, 2016, Legaspi became the first patient in San Diego to receive a new type of immunotherapy, known as CAR T-cell therapy, as part of a Phase I/II clinical trial at Moores Cancer Center at UC San Diego Health. His leukemia is now in remission again, more quickly and after a much better therapeutic experience.
Engineers at UC San Diego have developed a flexible wearable sensor that can accurately measure a person’s blood alcohol level from sweat and transmit the data wirelessly to a laptop, smartphone or other mobile device. The device can be worn on the skin and could be used by doctors and police officers for continuous, non-invasive and real-time monitoring of blood alcohol content.
The National Science Foundation (NSF) has awarded a five-year $15 million grant to a collaborative team led by the San Diego Supercomputer Center (SDSC) at UC San Diego to establish a Science Gateways Community Institute to accelerate the development and application of highly functional, sustainable science gateways that address the needs of researchers across the full spectrum of NSF directorates.